Market Report
Ergomed earnings to beat expectations for 2020
Specialist pharmaceutical service provider Ergomed updated the market on its trading in 2020 on Tuesday, saying it still expected revenue for the year ended 31 December to be in line with current market expectations, and adjusted EBITDA to be ahead of current expectations.
Trainline slumps on JPMorgan downgrade
Trainline shares slumped on Tuesday after JPMorgan Cazenove downgraded the stock to ‘neutral’ from ‘overweight’ and cut the price target to 382p from 486p as it pointed to the fact train usage remains weak due to Covid restrictions.
London open: Stocks gain despite uninspiring jobs data
London stocks edged higher in early trade on Tuesday despite the release of uninspiring UK jobs data and further weakness in the travel and leisure sector.
UDG Healthcare makes 'good start' to trading year
Healthcare services provider UDG Healthcare said on Monday that it had made "a good start" to the trading year, with first-quarter constant currency adjusted operating profit ahead of the same period a year earlier.
Apax fund to acquire insurance intermediary PIB
Apax Global Alpha said on Tuesday that the Apax X fund, in which it was a limited partner, has entered into a definitive agreement to acquire independent specialist insurance intermediary the PIB Group.
LXI REIT sees small increase in portfolio value
LXI REIT said on Tuesday that its portfolio has been valued by its independent valuer at £907. 25m as at 31 December, , reflecting a 1. 7% like-for-like increase on the 30 September valuation.
CMC Markets selects Amazon Web Services to aide digital transformation
Financial services company CMC Markets has selected Amazon Web Services to help deliver the next phase of its digital transformation.
Petropavlovsk misses production guidance for 2020
Petropavlovsk updated the market on 2020 on Tuesday, reporting total gold production for the year of 548,100 ounces, up 6% year-on-year.
Hikma mulls acquisition of GlaxoSmithKline assets in Egypt and Tunisia
Drugmaker Hikma Pharmaceuticals said on Tuesday that it has entered into a non-binding term sheet with GlaxoSmithKline to acquire certain parts of latter's assets in Egypt and Tunisia.
AstraZeneca gets approval for Symbicort Turbuhaler in China
AstraZeneca said on Tuesday that ‘Symbicort Turbuhaler’, with budesonide and formoterol, has been approved in China as an anti-inflammatory reliever to be taken as-needed in response to symptoms to achieve asthma control in patients with mild asthma aged 12 years and older.
Greencore Q1 revenues drop, current trading 'significantly' impacted by lockdwon
Convenience food producer Greencore reported a drop in first-quarter revenue on Tuesday as it said the latest national lockdown was "significantly" impacting demand.
Rolls-Royce expecting £2bn cash burn, AstraZeneca gets approval for Symbicort
London open The FTSE 100 is expected to open six points higher on Tuesday, having closed down 0. 84% on Monday at 6,638. 85.
London pre-open: Stocks seen muted as investors mull jobs data
London stocks were set for a muted open on Tuesday as investors digest the latest UK jobs data.
Tuesday newspaper round-up: Construction materials, tax reforms, emergency Covid schemes
A growing shortage of key construction materials could delay housebuilding this year as builders fight for fresh supplies against a backdrop of coronavirus-related challenges and price increases. One builders’ merchant said they were being given an August delivery date for roofing materials, such as pitched roof tiles, compared with a usual three-month wait because, even with extra shifts, UK factories were struggling to keep up. - Guardian.